Similarly, SRF was incorporated into mesoporous silica NPs (MMSNs) to generate MMSNs@SO NPs, which inhibited HepG2 tumor cells by depleting GSH, inhibiting intracellular GSH synthesis, and causing cancer cell ferroptosis [95]. Here, SRF is linked to cancer.